Jan. 1 - June 30, 1994 Shares TotalCompany VC Firm Bought* Market ValueGilead Sciences Inc. Menlo Ventures 243,826 $1,967,676CoCensys Inc. Sanderling Ventures 191,414 $921,641Genetic Therapy Inc. New Enterprise Associates 85,000 $781,250NPS Pharmaceuticals S.R. One 90,000 $495,000Genetic Therapy Inc. Oxford Bioscience Partners 53,400 $493,416CoCensys Inc. Domain Associates 79,438 $382,487 * Total shares bought between Jan. 1, 1994 and June 30, 1994according to Securities and Exchange Commissions filings. List onlyincludes purchases that had a total market value of more than $350,000in the time period stated.
Note: Recombinant Capital of San Francisco provided backgroundmaterial for this chart.
(c) 1997 American Health Consultants. All rights reserved.